Association of COX-2 gene SNPs with the risk of hepatocellular carcinoma

Chinese Journal of Cancer Prevention and Treatment

Volumn 18, Issue 6, 2011, Pages 405-409

  Fan, Xue Jiao ^a   Qiu, Xiao Qiang ^b   Yu, Hong Ping ^a   Zeng, Xiao Yun ^a   Yang, Yan ^a   Bei, Chun Hua ^a   Huang, Jin Mei ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma, hepatocellular; Genes, COX 2; Interaction; Single nucleotide polymorphism

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STRATIFIED SAMPLE;

EID: 80051987638     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aravalli R N, Steer C J, Cressman E N. Molecular mechanisms of hepatocellular carcinoma [J]. Hepatology, 2008, 48(6): 2047-2063.
2. Giannitrapani L, Ingrao S, Soresi M, et al. Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study [J]. Ann N Y Acad Sci, 2009, 1155: 293-299.
3. Wang D, Mann J R, DuBois R N. The role of prostaglandins and other eicosanoids in the gastrointestinal tract [J]. Gastroenterology, 2005, 128(5): 1445-1461. (Pubitemid 40712194)
4. Braeuer R R, Zigler M, Villares G J, et al. Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment [J]. Semin Cancer Biol, 2011, 21(2): 83-88.
5. Zhang X M, Miao X P, Tan W, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer [J]. Gastroenterology, 2005, 129(2): 565-576. (Pubitemid 41096644)
6. Akkiz H, Bayram S, Bekar A, et al. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma [J]. Mol Cell Biochem, 2011, 347(1-2): 201-208.
7. Yang H, Gu J, Lin X, et al. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition [J]. Clin Cancer Res, 2008, 14(7): 2236-2244. (Pubitemid 351551137)
8. Gangwar R, Mandhani A, Mittal R D, et al. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India [J]. Surgery, 2011, 149(1): 126-134.
9. Campa D, Zienolddiny S, Maggini V, et al. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer [J]. Carcinogenesis, 2004, 25(2): 229-235. (Pubitemid 38239806)
10. Hu Z, Miao X, Ma H, et al. A common polymorphism in the 3′ UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population[J]. Lung Cancer, 2005, 48(1): 11-17.
11. Pandey S, Mittal R D, Srivastava M, et al. Cyclooxygenase-2 gene polymorphis -ms and risk of cervical cancer in a North Indian population [J]. Int J Gynecol Cancer, 2010, 20(4): 625-630.
12. Zhu W, Wei B B, Shan X, et al. -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies[J]. Mol Biol Rep, 2010, 37(1): 277-288.
13. Pereira C, Pimentel-Nunes P, Brandao C, et al. COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention[J]. Eur J Gastroenterol Hepatol, 2010, 22(5): 607-613.
14. Langsenlehner U, Yazdani-Biuki B, Eder T, et al. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk [J]. Clin Cancer Res, 2006, 12(4): 1392-1394.